What's Happening?
Doximity, a digital platform for U.S. medical professionals, has acquired Pathway Medical Inc., a Montreal-based startup specializing in medical AI and evidence-based clinical reference, for $26 million in cash. The acquisition, which closed on July 29, 2025, aims to integrate Pathway's advanced AI platform and extensive medical dataset into Doximity's services. Pathway's AI model has achieved high accuracy on the U.S. Medical Licensing Examination benchmark, and the merger is expected to democratize access to these clinical tools for Doximity's vast network of users.
AD
Why It's Important?
The acquisition signifies a strategic move by Doximity to enhance its clinical reference capabilities, potentially transforming how medical professionals access and utilize evidence-based information. By integrating Pathway's AI-driven tools, Doximity can offer more accurate and efficient solutions to its users, which include over 80% of U.S. physicians. This development may lead to improved patient care and accelerated drug discovery, benefiting the healthcare industry and stakeholders involved in medical research and practice.
What's Next?
Following the acquisition, Doximity plans to integrate Pathway's technology into its platform, making advanced clinical tools available to millions of medical professionals. This integration may drive further innovation in healthcare technology and influence the adoption of AI in clinical settings. As Doximity expands its offerings, it may attract more users and partnerships, potentially reshaping the landscape of digital health solutions.
